Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NT5E | P21589 | 1/20 | 0.71 |
| ▸ | TGM2 | P21980 | 1/20 | 0.66 |
| ▸ | IMPDH2 | P12268 | 7/20 | 0.66 |
| ▸ | IMPDH1 | P20839 | 2/20 | 0.66 |
| ▸ | TAS1R3 | Q7RTX0 | 2/20 | 0.63 |
| ▸ | TAS1R1 | Q7RTX1 | 2/20 | 0.63 |
| ▸ | KRAS | P01116 | 5/20 | 0.60 |
| ▸ | FUT5 | Q11128 | 1/20 | 0.59 |
| ▸ | HINT1 | P49773 | 1/20 | 0.59 |
| ▸ | CA5A | P35218 | 1/20 | 0.58 |
| ▸ | POLB | P06746 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| E626 SCHEMBL13497991 | 0.92 | NT5E (0.83) | NT5ETGM2IMPDH2IMPDH1TAS1R3 | |
| E626 SCHEMBL18763818 | 0.92 | NT5E (0.83) | NT5ETGM2IMPDH2IMPDH1TAS1R3 | |
| E626 SCHEMBL18785103 | 0.92 | NT5E (0.83) | NT5ETGM2IMPDH2IMPDH1TAS1R3 | |
| E626 SCHEMBL5854 | 0.92 | NT5E (0.83) | NT5ETGM2IMPDH2IMPDH1TAS1R3 | |
| E626 SCHEMBL20677331 | 0.92 | NT5E (0.83) | NT5ETGM2IMPDH2IMPDH1TAS1R3 | |
| E626 SCHEMBL165027 | 0.92 | NT5E (0.83) | NT5ETGM2IMPDH2IMPDH1TAS1R3 | |
| E626 SCHEMBL20277596 | 0.92 | NT5E (0.83) | NT5ETGM2IMPDH2IMPDH1TAS1R3 | |
| E626 SCHEMBL21803790 | 0.92 | NT5E (0.83) | NT5ETGM2IMPDH2IMPDH1TAS1R3 | |
| E626 SCHEMBL21163348 | 0.92 | NT5E (0.83) | NT5ETGM2IMPDH2IMPDH1TAS1R3 | |
| E626 SCHEMBL18759049 | 0.92 | NT5E (0.83) | NT5ETGM2IMPDH2IMPDH1TAS1R3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8304529-B2 | Dinucleotide MRNA cap analogs | Life Technologies Corporation (US) | 2012-11-06 | — | — | US | disclosed |